Cara Therapeutics (CARA) FCF/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -1.19 | -1.47 | -1.75 | -1.36 | 0.00 | 0.00 | |||
| Changes by years, y/y, % | +863% | +24% | +19% | -22% | -100% | -51.9% | |||
Cara Therapeutics. FCF/share, rub
Cara Therapeutics. FCF/share, changes, %
Cara Therapeutics (CARA) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF/share, rub | -0.31 | -0.11 | -0.05 | 0.00 | 0.00 | 0.00 | ||
| Changes by years, y/y, % | -46% | -53% | -82% | -99% | -100% | |||
| Changes by quarters, q/q, % | +318% | -65% | -58% | -98% | -18% | |||